Zhejiang Hengyu Biological Technology provides bioassay and quality testing services for cell and gene therapies.
Founded in 2020, Zhejiang Hengyu Biological Technology provides biosafety testing, analytical validation, and quality control services for cell and gene therapy products. It is based in Jiaxing, China, with an R&D center in Shanghai, and has served nearly 200 biopharmaceutical companies by 2024. In March 2024, it raised approximately CNY 200 million in Series B funding to expand its services and overseas business.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Zhejiang Hengyu Biological Technology CO.,Ltd? This is my company